Song, Y. (2025). TGM2 as a novel therapeutic target in venetoclax-resistant AML: Disrupting histone serotonylation-driven mitophagy with nanoparticle-delivered inhibitors. Blood. https://doi.org/10.1182/blood-2025-5058